Valuation: Zoetis Inc.

Market Cap 28.55B 25.36B 23.72B 21.61B 40.69B 2,749B 41.25B 287B 111B 1,400B 107B 105B 4,497B P/E 2026 *
12.3x
P/E 2027 * 11.6x
Enterprise Value 35.67B 31.69B 29.63B 27B 50.84B 3,435B 51.54B 358B 139B 1,749B 134B 131B 5,619B EV / Sales 2026 *
3.86x
EV / Sales 2027 * 3.69x
Free-Float
82.35%
Yield 2026 *
3.06%
Yield 2027 * 3.29%
1 day-1.54%
1 week+0.75%
Current month-0.39%
1 month-7.81%
3 months-5.17%
6 months-39.59%
Current year-42.57%
1 week 61.22
Extreme 61.22
62.98
1 month 61.16
Extreme 61.16
67
Current year 61.16
Extreme 61.16
114.98
1 year 61.16
Extreme 61.16
128.16
3 years 61.16
Extreme 61.16
185
5 years 61.16
Extreme 61.16
221
10 years 61.16
Extreme 61.16
221
Manager TitleAgeSince
Chief Executive Officer 54 2019-12-31
Director of Finance/CFO 53 2026-08-16
Chief Tech/Sci/R&D Officer 49 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2012-06-30
Director/Board Member 68 2012-12-31
Chairman 73 2013-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%+0.75% - - 28.55B
-0.62%-2.71%+39.30%+114.07% 1,025B
-2.30%-4.44%+39.03%+66.07% 623B
-0.63%-1.96%+6.36%+74.38% 459B
-1.03%-2.82%+59.56%+39.69% 355B
-0.07%-3.19%+22.69%+40.62% 336B
+0.14%-1.19%+13.81%+26.79% 270B
-0.03%-4.05%-3.29%+9.99% 247B
-3.38%+0.30%+36.44%+51.54% 220B
-1.04%-1.46%+32.70%+96.82% 183B
Average -1.06%-1.89%+27.40%+57.77% 413.14B
Weighted average by Cap. -1.00%-2.11%+30.45%+69.59%

Financials

2026 *2027 *
Net sales 9.23B 8.2B 7.67B 6.99B 13.16B 889B 13.34B 92.8B 35.92B 453B 34.67B 33.92B 1,454B 9.47B 8.41B 7.86B 7.17B 13.49B 912B 13.68B 95.14B 36.83B 464B 35.55B 34.78B 1,491B
Net income 2.36B 2.1B 1.96B 1.79B 3.36B 227B 3.41B 23.73B 9.18B 116B 8.87B 8.67B 372B 2.38B 2.12B 1.98B 1.8B 3.39B 229B 3.44B 23.93B 9.26B 117B 8.94B 8.75B 375B
Net Debt 7.12B 6.32B 5.91B 5.39B 10.15B 686B 10.29B 71.55B 27.7B 349B 26.73B 26.15B 1,121B 6.38B 5.67B 5.3B 4.83B 9.09B 614B 9.22B 64.1B 24.81B 313B 23.95B 23.43B 1,005B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
26-10-02 €61.62 -1.12% 409
26-10-01 €62.32 +0.74% 1,675
26-09-30 €61.86 -0.74% 602
26-09-29 €62.32 +0.74% 637
26-09-28 €61.86 +1.14% 647
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
69.10USD
Average target price
96.00USD
Spread / Average Target
+38.93%

Quarterly revenue - Rate of surprise